Pediatrix Medical Group, Inc. (MD)
| Market Cap | 1.86B |
| Revenue (ttm) | 1.91B |
| Net Income (ttm) | 165.39M |
| Shares Out | 81.14M |
| EPS (ttm) | 1.94 |
| PE Ratio | 11.84 |
| Forward PE | 10.28 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 617,969 |
| Open | 23.51 |
| Previous Close | 23.39 |
| Day's Range | 22.94 - 23.68 |
| 52-Week Range | 11.84 - 24.99 |
| Beta | 0.72 |
| Analysts | Hold |
| Price Target | 20.50 (-10.71%) |
| Earnings Date | May 5, 2026 |
About MD
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fe... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for MD stock is "Hold." The 12-month stock price target is $20.5, which is a decrease of -10.71% from the latest price.
News
Ambience Healthcare Appoints Michael Han, MD, MBA as Chief Medical Officer
SAN FRANCISCO--(BUSINESS WIRE)--Ambience Healthcare, the leading AI platform for clinical documentation and revenue integrity, today announced the appointment of Michael Han, MD, MBA as Chief Medical ...
Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026.
Pediatrix Expands Maternal Health Services in Tennessee in Partnership with Tennessee Maternal-Fetal Medicine
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Expands Maternal Health Services in Tennessee in Partnership with Tennessee Maternal-Fetal Medicine.
Pediatrix Welcomes Two Nationally Renowned Physician Leaders
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Welcomes Two Nationally Renowned Physician Leaders.
Pediatrix Medical Group Announces 47th Annual NEO: The Conference for Neonatology
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Announces 47th Annual NEO: The Conference for Neonatology.
Pediatrix Medical Group Earnings Call Transcript: Q4 2025
Q4 2025 capped a strong year with adjusted EBITDA of $66M and full-year $276M, driven by favorable payer mix, acuity, and disciplined cost control. 2026 guidance projects flat revenue at $1.9B and 5% EBITDA growth, with steady operational metrics and no M&A included.
Pediatrix Medical Group Reports Fourth Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Fourth Quarter Results.
Pediatrix Medical Group 2025 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 19, 2026
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 19, 2026.
Pediatrix Medical Group Earnings Call Transcript: Q3 2025
Adjusted EBITDA for Q3 2025 exceeded expectations at $87 million, driven by strong pricing, collections, and expense controls. Portfolio restructuring and acquisitions enhanced focus and performance, while full-year adjusted EBITDA guidance is set at $270–$290 million.
Pediatrix Medical Group Reports Third Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results; Raises Full Year 2025 Adjusted EBITDA Outlook Range.
Pediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025.
Pediatrix Medical Group Announces $250 Million Share Repurchase Program
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Announces $250 Million Share Repurchase Program.
Pediatrix Medical Group Earnings Call Transcript: Q2 2025
Q2 2025 adjusted EBITDA exceeded expectations, driven by strong same-unit revenue and NICU growth, while portfolio restructuring reduced total revenue. Full-year EBITDA guidance was raised, cash flow and balance sheet remain strong, and management is confident navigating regulatory and market headwinds.
Pediatrix Medical Group Reports Second Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Second Quarter Results.
Pediatrix Medical Group 2025 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 5, 2025
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 Second Quarter Conference Call/Webcast Scheduled for Tuesday, August 5, 2025.
Pediatrix Board Appoints Kurt D. Newman, M.D.
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Board Appoints Kurt D. Newman, M.D. as Independent Director.
Pediatrix Medical Group Earnings Call Transcript: Q1 2025
First quarter results exceeded expectations with strong same-unit revenue and NICU volume growth, leading to a raised 2025 adjusted EBITDA outlook. Portfolio restructuring improved cost structure, and management remains cautious due to ongoing economic and healthcare uncertainty.
Pediatrix Medical Group Reports First Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports First Quarter Results.
Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025.
Top 3 Health Care Stocks You May Want To Dump In February
As of Feb. 20, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Pediatrix Q4 Beats Estimates As Operational Improvements Drive Performance
On Thursday, Pediatrix Medical Group, Inc. MD reported fourth-quarter sales of $502.36 million. That's up from $496.4 million a year ago, beating the consensus of $486.21 million.
Pediatrix Medical Group Earnings Call Transcript: Q4 2024
Strong Q4 and year-end results were driven by favorable payer mix, volume growth, and portfolio restructuring, with Adjusted EBITDA exceeding guidance. 2025 outlook is cautious due to industry headwinds, with a focus on operational efficiency and maintaining a strong balance sheet.
Pediatrix Medical Group to Host Premier Neonatology Conference Feb. 19-21
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD #ContinuingEducation--NEO: The Conference for Neonatology is a premier educational event dedicated to advancing the field of neonatology.
Pediatrix Medical Group 2024 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 20, 2025
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2024 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 20, 2025.
Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation.